Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4932359 | Journal of Substance Abuse Treatment | 2017 | 6 Pages |
Abstract
HRQoL measures are rarely used as outcomes in opioid treatment programs. The field should incorporate HRQoL measures as standard practice, especially measures that can be used to derive utility weights, such as the SF-12 or EQ-5D. These instruments provide policy makers with evidence on the impact of programs on patients' lives and with data to quantify the value of investing in opioid use disorder treatments.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Jeremy W. Bray, Brandon Aden, Ashley A. Eggman, Leah Hellerstein, Eve Wittenberg, Bohdan Nosyk, Judy C. Stribling, Bruce R. Schackman,